Compare PGEN & IOSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | IOSP |
|---|---|---|
| Founded | 1998 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2013 | 1998 |
| Metric | PGEN | IOSP |
|---|---|---|
| Price | $3.34 | $74.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.67 | ★ $124.00 |
| AVG Volume (30 Days) | ★ 4.6M | 186.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.26% |
| EPS Growth | N/A | ★ 228.87 |
| EPS | N/A | ★ 4.67 |
| Revenue | $230,981,000.00 | ★ $1,778,000,000.00 |
| Revenue This Year | $342.78 | $5.96 |
| Revenue Next Year | $478.46 | $6.10 |
| P/E Ratio | ★ N/A | $16.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $70.10 |
| 52 Week High | $5.47 | $102.26 |
| Indicator | PGEN | IOSP |
|---|---|---|
| Relative Strength Index (RSI) | 32.84 | 29.37 |
| Support Level | $2.99 | $70.58 |
| Resistance Level | $5.10 | $76.78 |
| Average True Range (ATR) | 0.33 | 2.59 |
| MACD | -0.13 | -1.01 |
| Stochastic Oscillator | 3.85 | 2.77 |
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.